Survival analysis was performed using the HPA database, and the results showed that the survival time of HCC patients with high TRMT6 expression (n = 182) was significantly lower than that of HCC patients with low TRMT6 expression (n = 183) (Fig. 1B). Here, TRMT6 is linked to hepatocellular carcinoma.